StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)

Close on Nov 18, 2026Market cap $18.06MP/E –Yield –

Atossa Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Atossa Therapeutics's price to sales ratio was 339.6× on Jan 30, 2015, against 63.0× a year earlier. Over the last 2 years it ranged from 36.1× to 415.0×, with a median of 120.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jan 30, 2015339.6×−75.5
2014Dec 31, 2014415.0×+355.8
2013Dec 31, 201359.2×−63.6
2012Dec 31, 2012122.8×–

More Atossa Therapeutics figures

See a number that looks wrong?